Frontlight ResearchEarly access
Trial site
Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz Koerperschaft Des Offentlichen Rechts
- 4running trials
- 10closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Liver and biliary tract cancer2 trials
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Psoriasis1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 11 trial
- Status
- Completed10 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Akero Therapeutics Inc.1 trial
- Almirall S.A.1 trial
- Arctic Bioscience AS1 trial
- Australasian Gastro-Intestinal Trials Group1 trial
- and 8 more
Running trials
Recruiting
Recruiting
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7.
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026